Incidence of hypomagnesemia in patients with HER2+breast cancer treated with pertuzumab.

被引：0
|
作者：
Shah, Nirja
Daily, Karen Colleen
机构：
[1] Univ Florida, Coll Med, Gainesville, FL USA
[2] Univ Florida, UF Hlth Canc Ctr, Gainesville, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12569
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Treatment of ER+/HER2+breast cancer
    Johnston, Stephen
    CANCER RESEARCH, 2023, 83 (05)
  • [42] Effect of FAK Activation HER2+Breast Cancer
    Quintana, Victoria Gabriela
    Byrd, Sherell
    FASEB JOURNAL, 2019, 33
  • [43] Real-world data on outcomes using taxane, trastuzumab, and pertuzumab (THP) in patients with early stage HER2+breast cancer.
    Sharma, Harsh
    Kreutzfeldt, Jordyn
    Mehta, Tej
    Farr, Kiah
    Brown-Glaberman, Ursa
    Chalasani, Pavani
    Nemunaitis, Jacklyn
    Segar, Jennifer Margaret
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] In-Depth Analysis of the Peripheral Immune Profile of HER2+Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab
    Viglietti, Ayelen Ivana Pesce
    Bordignon, Maria Belen
    Ostinelli, Alexis
    Rizzo, Manglio Miguel
    Cueto, Gerardo
    Sanchez, Maria Belen
    Perazzo, Florencia
    Amat, Mora
    Colo, Federico
    Costanzo, Maria Victoria
    Nervo, Adrian
    Nadal, Jorge
    Crimi, Gabriel
    Mc Lean, Ignacio
    Spengler, Eunice Amancay
    Mordoh, Jose
    Mando, Pablo
    Levy, Estrella Mariel
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
  • [45] Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab
    Bergen, Elisabeth Sophie
    Binter, Amelie
    Starzer, Angelika Martina
    Heller, Gerwin
    Kiesel, Barbara
    Tendl-Schulz, Kristina
    Bago-Horvath, Zsuzsanna
    Furtner, Julia
    Leitner, Johannes
    Exner, Ruth
    Fitzal, Florian
    Dieckmann, Karin
    Widhalm, Georg
    Preusser, Matthias
    Berghoff, Anna Sophie
    Bartsch, Rupert
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [46] Intrinsic molecular subtypes of HER2+breast cancer
    Prat, Aleix
    Pascual, Tomas
    Adamo, Barbara
    ONCOTARGET, 2017, 8 (43) : 73362 - 73363
  • [47] Recent insights into the biology of HER2+breast cancer
    Prat, A.
    CANCER RESEARCH, 2017, 77
  • [48] Survival after brain metastases in Asian patients with HER2+breast cancer
    Yap, Y. S.
    Devi, B. C.
    Khorprasert, C.
    Cornelio, G. H.
    Sutandyo, N.
    Yeoh, E.
    Landis, S.
    Kobayashi, M.
    Moon, H.
    Ro, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [49] Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab
    Al Rabadi, Luai S.
    Cook, Madeline M.
    Kaempf, Andy J.
    Saraceni, Megan M.
    Savin, Michael A.
    Mitri, Zahi, I
    BMC CANCER, 2021, 21 (01)
  • [50] Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab
    Luai S. Al Rabadi
    Madeline M. Cook
    Andy J. Kaempf
    Megan M. Saraceni
    Michael A. Savin
    Zahi I. Mitri
    BMC Cancer, 21
12345